Close mobile menu×
Close mobile menu

Anne-Catrin Uhlemann, MD, PhD

Board Certifications: 
Infectious Disease, Internal Medicine
Not Accepting New Patients
Profile Hero

Appointments

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Infectious Disease
  • Internal Medicine

Clinical Expertise

  • Bacterial Infection
  • Infectious Disease
  • Organ Transplant Infections
  • Staphylococcal Infection

Specialties

Education & Training

  • Eberhard-Karls University (Germany)
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

2014 - 2017 Florence Irving Assistant Professor of Medicine

2010 - 2013 Paul A. Marks Scholar, Columbia University

About Anne-Catrin Uhlemann

Dr. Anne-Catrin Uhlemann is the Florence Irving Assistant Professor of Medicine in the Division of Infectious Diseases in the College of Physicians and Surgeons at Columbia University.

Academic Titles

  • Associate Professor of Medicine

Committee/Societies/Council Memberships

Member, American Society of Microbiology
Member, Infectious Diseases Society of America

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
180 Fort Washington Avenue
Suite 2-242
New York, New York 10032
Phone:
(212) 305-8039
Fax:
(212) 305-1754
Primary

Research

Dr. Anne-Catrin Uhlemann's laboratory investigates the evolution of bacterial pathogens such as Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae.

Research Interests

  • Bacterial evolution
  • Multi-drug resistant infections

Grants

INNATE IMMUNE CLEARANCE OF HOST-ADAPTED PULMONARY PATHOGENS (Federal Gov)

Jan 11 2017 - Nov 30 2023

DEVELOPMENT AND SIGNIFICANCE OF THE PLASMA CELL NICHE IN THE HUMANINFANT THYMUS (Federal Gov)

Aug 23 2017 - Jul 31 2022

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Jul 1 2016 - May 31 2021

BACTEREMIA DUE TO CARBAPENEMRESISTANT ENTEROBACTERIACEAE IN NEW YORK CITY IN THE ERA OF RAPID DIAGNOSIS AND CEFTAZIDINE-AVIBACTAM: A MULTICENTER STUDY (CAZ-IT-21) (Private)

Nov 5 2018 - Nov 4 2020

CARBAPENEM-RESISTANT BACTERIAL COLONIZATION AND INFECTION IN LIVER TRANSPLANT (Federal Gov)

Jan 14 2015 - Dec 31 2019

ACTIVITY OF IMIPENEM-RELEBACTAM IN DIVERSE EMERGING CRE: A COMBINED EPIDEMIOLOGICAL AND GENOMICS APPROACH (Private)

Apr 6 2016 - Apr 5 2018

MECHANISMS OF S. AUREUS TRANSMISSION AND PERSISTENCE (Federal Gov)

Jul 1 2010 - Jun 30 2016

NYPH TRANSLATIONAL GRANT SUBCONTRACT (NY State Gov)

Jul 1 2014 - Jun 30 2015

THE USE OF WHOLE GENOME SEQUENCING TO IDENTIFY SPREAD OF USA300 IN THE COMMUNITY (Federal Gov)

Feb 11 2013 - Jan 31 2015

Selected Publications

Austin ED, Sullivan SB, Whittier S, Lowy FD, Uhlemann AC. Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection. Open Forum Infect Dis. 2016 Apr 6;3(2):ofw072. eCollection 2016 Mar.

Gomez-Simmonds A, Hu Y, Sullivan SB, Wang Z, Whittier S, Uhlemann AC. Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007 – 2014. J Antimicrob Chemother 2016; 71(8):2351-3.

Pereira MR, Uhlemann AC. The evolving threat of carbapenem-resistant infections after liver transplantation: The case of Acinetobacter baumannii. Liver Transpl. 2016 May;22(5):579-81.

Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, Uhlemann AC. Population structure of Klebsiella pneumoniae causing bloodstream infections at a New York City tertiary care hospital: diversification of multidrug-resistant isolates. J Clin Microbiol 2015 Jul;53(7):2060-7.

Uhlemann AC, Dordel J, Knox JR, Raven K, Parkhill J, Holden MT, Peacock SJ, Lowy FD. Molecular tracing of the emergence, diversification and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci U S A 2014; 111(18):6738-43.

Sowash MG, Uhlemann AC. Community-associated methicillin-resistant Staphylococcus aureus case studies. Methods Mol Biol. 2014;1085:25-69. Review.

Uhlemann AC, Hafer C, Miko BA, Sowash MG, Sullivan SB, Shu Q, Lowy FD. Emergence of sequence type 398 as a community- and healthcare-associated methicillin-susceptible Staphylococcus aureus in Northern Manhattan. Clin Infect Dis 2013; 57:700-3.

Uhlemann AC, Porcella SF, Trivedi S, Sullivan SB, Hafer C, Kennedy AD, Barbian KD, McCarthy AJ, Street C, Hirschberg DL, Lipkin WI, Lindsay JA, DeLeo FR, Lowy FD. Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. mBio 2012; 3: e00027-12.

Uhlemann AC, Kennedy AD, Martens C, Porcella SF, Deleo FR, Lowy FD. Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community households. Genome Biol Evol 2012; 4:1275-85.

Hafer C, Lin Y, Kornblum J, Lowy FD, Uhlemann AC. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56:5845-51.

Uhlemann AC, Fidock DA. Loss of malarial susceptibility to artemisinin in Thailand. Lancet 2012 379(9830):1928-30.